Sava Technologies 🇬🇧
Wearable microsensors for continuous glucose and biomarker monitoring
About Sava Technologies
The product utilizes advanced biosensing technology for real-time, minimally invasive monitoring of multiple molecules just beneath the skin, enabling continuous health data collection. This system provides users with seamless access to essential health information, supporting proactive health management.
Sava Technologies is a UK-based company founded in 2016, now around 167 people. It has raised $36M in disclosed funding.
Founded by Rafaël Michali (Co-Founder & Co-CEO; Imperial College London), Renato Circi (Co-Founder & Co-CEO; previously The Ortus Club; Imperial College London).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Series B · $36M · Oct 2026
- Balderton Capital — Balderton Capital is a Early-Stage Venture Capital Investor. · cheques £3M – £20M
- JamJar Investments — JamJar Investments is a venture capital firm that invest in high growth digital Consumer brand businesses. · cheques £250k – £3M
- Norrsken VC — Norrsken VC is a Stockholm-based impact VC fund investing in start-ups solving the world's biggest problems while building massive businesses · cheques £1M – £15M